1672.0000 9.50 (0.57%)
NSE Jul 11, 2025 15:31 PM
Volume: 1.3M
 

1672.00
0.57%
Axis Direct
Sun Pharma: Launched its first specialty ophthalmic drug, Bromsite (in-site pipeline) in the US in Q3'17; Dilip Buildcon: Diversifying to access adjacent revenue stream
Sun Pharmaceutical I.. has an average target of 2105.29 from 7 brokers.
More from Sun Pharmaceutical Industries Ltd.
Recommended